Prevalence of peripheral arterial disease in patients at non-high cardiovascular risk. Rationale and design of the PANDORA study

BMC Cardiovascular Disorders

Volumn 10, Issue , 2010, Pages

  Cimminiello, Claudio ^a   Borghi, Claudio ^b   Kownator, Serge ^c   Wautrecht, Jean C ^d   Carvounis, Christos P ^e   Kranendonk, Stefanus E ^f   Kindler, Beat ^g   Mangrella, Mario ^h  

^a DESIO HOSPITAL   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Clinique Ambroise Paré   (France)

^d ERASME HOSPITAL   (Belgium)

^e Blue Cross Hospital   (Greece)

^f CPRLab   (Netherlands)

^g HIV Pract   (Switzerland)

^h ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANKLE BRACHIAL INDEX; ARTICLE; BELGIUM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; FRANCE; GREECE; HIGH RISK POPULATION; ITALY; NETHERLANDS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREVALENCE; PRIORITY JOURNAL; SWITZERLAND; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPIDEMIOLOGY; EUROPE; HUMAN; MEDICAL SOCIETY; METABOLISM; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; UNITED STATES;

BIOLOGICAL MARKER;

AMERICAN HEART ASSOCIATION; ANKLE BRACHIAL INDEX; BIOLOGICAL MARKERS; EPIDEMIOLOGIC RESEARCH DESIGN; EUROPE; HUMANS; PERIPHERAL ARTERIAL DISEASE; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; UNITED STATES;

EID: 77955179175     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-10-35     Document Type: Article

References (19)

1. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM, Hiatt WR. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001, 286:1317-1324. 10.1001/jama.286.11.1317, 11560536.
2. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM, White CJ, White J, White RA, Antman EM, Smith SC, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol 2006, 47:1239-1312. 10.1016/j.jacc.2005.10.009, 16545667.
3. Sans S, Kesteloot H, Kromhout D, . on behalf of the Task Force The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J 1997, 18:1231-1248. on behalf of the Task Force.
4. British Heart Foundation European Cardiovascular Disease Statistics. London 2005, British Heart Foundation.
5. Murabito JM, D'Agostino RB, Silbershatz H, Wilson WF. Intermittent claudication. A risk profile from The Framingham Heart Study. Circulation 1997, 96:44-49.
6. Treat-Jacobson D, Halverson SL, Ratchford A, Regensteiner JG, Lindquist R, Hirsch AT. A patient-derived perspective of health-related quality of life with peripheral arterial disease. J Nursing Scholarsh 2002, 34:55-60.
7. Steg PG, Bhatt DL, Wilson PWF, D'Agostino R, Ohman EM, Röther J, Liau CS, Hirsch AT, Mas JL, Ikeda Y, Pencina MJ, Goto S, . REACH Registry Investigators One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007, 297:1197-1206. 10.1001/jama.297.11.1197, 17374814, REACH Registry Investigators.
8. Hirsch AT, Murphy TP, Lovell MB, Twillman G, Treat-Jacobson D, Harwood EM, Mohler ER, Creager MA, Hobson RW, Robertson RM, Howard WJ, Schroeder P, Criqui MH, . Peripheral Arterial Disease Coalition Gaps in public knowledge of peripheral arterial disease the first national PAD public awareness survey. Circulation 2007, 116:2086-2094. 10.1161/CIRCULATIONAHA.107.725101, 17875966, Peripheral Arterial Disease Coalition.
9. Tzou WS, Mohler ER III. Peripheral arterial disease: diagnosis and medical management. Hosp Physician 2006, 42:17-25.
10. Hooi JD, Stoffers HE, Kester AD, Rinkens PE, Kaiser V, van Ree JW, Knottnerus JA. Risk factors and cardiovascular diseases associated with asymptomatic peripheral arterial occlusive disease. The Limburg PAOD Study. Peripheral arterial occlusive disease. Scand J Prim Health Care 1998, 16:177-182. 10.1080/028134398750003142, 9800232.
11. Hooi JD, Kester AD, Stoffers HE, Overdijk MM, van Ree JW, Knottnerus JA. Incidence of and risk factors for asymptomatic peripheral arterial occlusive disease: a longitudinal study. Am J Epidemiol 2001, 153:666-672. 10.1093/aje/153.7.666, 11282794.
12. National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation and, treatment of high blood cholesterol in adults (Adult Treatment Panel III) Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and, treatment of high blood cholesterol in adults (Adult Treatment Panel III): final report. Circulation 2002, 106:3143-3121. National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation and, treatment of high blood cholesterol in adults (Adult Treatment Panel III).
13. Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Stone NJ, . National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004, 110:227-239. 10.1161/01.CIR.0000133317.49796.0E, 15249516, National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association.
14. Fowkes FGR, Low LP, Tuta S, Kozak J, . AGATHA Investigators Ankle-brachial index and extent of atherothrombosis in 8891 patients with or at risk of vascular disease: results of the international AGATHA study. Eur Heart J 2006, 27:1861-1867. 10.1093/eurheartj/ehl114, 16820367, AGATHA Investigators.
15. Hiatt WR. Medical treatment of peripheral arterial disease and claudication. New Engl J Med 2001, 344:1608-1621. 10.1056/NEJM200105243442108, 11372014.
16. Cacoub P, Cambou JP, Kownator S, Belliard JP, Beregi JP, Branchereau A, Carpentier P, Léger P, Luizy F, Maïza D, Mihci E, Herrmann MA, Priollet P. Prevalence of peripheral arterial disease in high-risk patients using ankle-brachial index in general practice: a cross-sectional study. Int J Clin Pract 2009, 63:63-70. 10.1111/j.1742-1241.2008.01953.x, 2705819, 19125994.
17. Diehm C, Lange S, Darius H, Pittrow D, von Stritzky B, Tepohl G, Haberl RL, Allenberg JR, Dasch B, Trampisch HJ. Association of low ankle brachial index with high mortality in primary care. Eur Heart J 2006, 27:1743-1749. 10.1093/eurheartj/ehl092, 16782720.
18. Kannel WB. The demographics of claudication and the aging of the American population. Vasc Med 1996, 1:60-64.
19. Greenland P, Abrams J, Aurigemma GP, Bond MG, Clark LT, Criqui MH, Crouse JR, Friedman L, Fuster V, Herrington DM, Kuller LH, Ridker PM, Roberts WC, Stanford W, Stone N, Swan HJ, Taubert KA, Wexler L. Prevention Conference V. Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation 2000, 101:e16-e22.